panCELLa has created platforms  that allow for the development of safe, universal, “off-the-shelf” cell lines. Our mandate is to accelerate cell-based therapies to a broad range of diseases by providing safe therapeutic cell products.  We license cell lines incorporated with our FailSafeTM and induced Allogeneic Cell Tolerance (iACT Stealth CellsTM) in addition to developing our own MSC- and NK-based therapeutic products.

panCELLa Logo



Event details

Date: June 8 - 12, 2020

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


34 in total